24 HR alprazolam 1 MG Extended Release Oral Tablet [Xanax] — RxCUI 687024
RxNorm drug concept · Semantic branded drug
RxCUI 687024
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI687024
Official name24 HR alprazolam 1 MG Extended Release Oral Tablet [Xanax]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Xanax 1 MG Extended Release Oral Tablet; Xanax XR 1 MG 24HR Extended Release Oral Tablet; Xanax XR 1 MG 24 HR Extended Release Oral Tablet
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Alprazolam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Alprazolam is used to treat generalized anxiety disorder (GAD) and panic disorder — including panic disorder that involves a fear of being in public places (agoraphobia). Different...
- It can, especially when you first start taking it or if your dose changes. Sedation, sleepiness, and memory or concentration issues are among the most commonly reported side effect...
- Will alprazolam make me feel drowsy or foggy?
- Please don't stop on your own — this is really important. Your body can become physically dependent on alprazolam even after short-term use, and stopping suddenly can trigger serio...
🕸️ Concept Web — How 24 HR alprazolam 1 MG Extended Release Oral Tabl... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR alprazolam 1 MG Extended Release Oral Tablet [Xanax]
RxCUI 687024 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Alprazolam
596IN
-
Alprazolam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xanax
202363BN
-
Xanax
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Alprazolam Extended Release Oral Tablet
370816SCDF -
Alprazolam Oral Product
1155284SCDG -
Alprazolam Pill
1155285SCDG -
Alprazolam Extended Release Oral Tablet [Xanax]
687021SBDF -
Xanax Oral Product
1186300SBDG -
Xanax Pill
1186301SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Alprazolam Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
24 HR alprazolam 1 MG Extended Release Oral Tablet
433800SCD -
Alprazolam 1 MG
315315SCDC -
Alprazolam 1 MG [Xanax]
573847SBDC
-
24 HR alprazolam 1 MG Extended Release Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
24 HR alprazolam 1 MG Extended Release Oral Tablet
SCD · 433800 -
Alprazolam 1 MG
SCDC · 315315 -
Alprazolam Extended Release Oral Tablet
SCDF · 370816 -
Alprazolam Oral Product
SCDG · 1155284 -
Alprazolam Pill
SCDG · 1155285
Brand-Name Concepts
-
Alprazolam 1 MG [Xanax]
SBDC · 573847 -
Alprazolam Extended Release Oral Tablet [Xanax]
SBDF · 687021 -
Xanax Oral Product
SBDG · 1186300 -
Xanax Pill
SBDG · 1186301 -
Xanax
BN · 202363
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 687024 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58151-0503-91 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-503-91) | Xanax XR | Viatris Specialty LLC | 2024-05-21 |
| 58151-0504-91 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-504-91) | Xanax XR | Viatris Specialty LLC | 2024-06-20 |
| 58151-0505-91 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-505-91) | Xanax XR | Viatris Specialty LLC | 2024-08-01 |
| 58151-0506-91 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-506-91) | Xanax XR | Viatris Specialty LLC | 2024-07-26 |
Observed labelers:
Viatris Specialty LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.